Neutropenia: Progression, Duration, and Recovery
| Degree of Neutropenia . | Patients Reaching Level . | Median Day of Onset . | Median Duration (range) in Days . | Died Without Recovery . | Progress Down to Next Level . | Recovered . |
|---|---|---|---|---|---|---|
| (ANC/μL) . | (n = 278) . | (range) . | . | . | . | . |
| <1,500 | 159 (57%) | 64 (18-100) | 13 (2-67) | 1 | 112 (70%) | 44 |
| <1,000 | 112 (40%) | 66 (18-100) | 9 (2-53) | 0 | 87 (78%) | 25 |
| <750* | 87 (31%) | 69 (25-102) | 6 (2-40) | 5 | 56 (64%) | 26 |
| <500 | 56 (21%) | 72 (31-105) | 3 (2-38) | 7 | 19 (34%) | 30 |
| <200 | 19 (7%) | 74 (35-96) | 7 (2-20) | 6 | — | 13 |
| Degree of Neutropenia . | Patients Reaching Level . | Median Day of Onset . | Median Duration (range) in Days . | Died Without Recovery . | Progress Down to Next Level . | Recovered . |
|---|---|---|---|---|---|---|
| (ANC/μL) . | (n = 278) . | (range) . | . | . | . | . |
| <1,500 | 159 (57%) | 64 (18-100) | 13 (2-67) | 1 | 112 (70%) | 44 |
| <1,000 | 112 (40%) | 66 (18-100) | 9 (2-53) | 0 | 87 (78%) | 25 |
| <750* | 87 (31%) | 69 (25-102) | 6 (2-40) | 5 | 56 (64%) | 26 |
| <500 | 56 (21%) | 72 (31-105) | 3 (2-38) | 7 | 19 (34%) | 30 |
| <200 | 19 (7%) | 74 (35-96) | 7 (2-20) | 6 | — | 13 |
Ganciclovir was discontinued when the ANC was less than 750/μL for 2 consecutive days.